Handelen Biogaia B - BIOGb CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Spread | 4.1 | ||||||||
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.025632% | ||||||||
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | -0.018813% | ||||||||
Tijd van overnight-tarief | 22:00 (UTC) | ||||||||
Min. verhandelde hoeveelheid | 1 | ||||||||
Valuta | SEK | ||||||||
Marge | 20% | ||||||||
Effectenbeurs | Sweden | ||||||||
Handelscommissie | 0% |
*Information provided by Capital.com
Biogaia AB ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 93.4 |
Open* | 93.3 |
1-Jaarlijkse Verandering* | -81.37% |
Dagelijks bereik* | 92.4 - 95.6 |
52 wekelijks bereik | 68.88-125.60 |
Weekgemiddelde volume (10 dagen) | 85.91K |
Gemiddeld volume (3 maanden) | 1.89M |
Marktkapitalisatie | 9.16B |
P/E Ratio | 34.89 |
Uitstaande Aandelen | 100.98M |
Omzet | 1.04B |
EPS | 2.70 |
Dividend (opbrengst %) | 1.5414 |
Beta | 0.72 |
Volgende inkomsten datum | Feb 3, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
---|---|---|---|---|---|---|
Feb 1, 2023 | 93.4 | 1.5 | 1.63% | 91.9 | 93.9 | 91.8 |
Jan 31, 2023 | 90.9 | -0.1 | -0.11% | 91.0 | 91.6 | 90.8 |
Jan 30, 2023 | 91.6 | 0.5 | 0.55% | 91.1 | 91.6 | 90.2 |
Jan 27, 2023 | 91.7 | 0.8 | 0.88% | 90.9 | 92.2 | 90.3 |
Jan 26, 2023 | 90.3 | -2.3 | -2.48% | 92.6 | 93.0 | 90.3 |
Jan 25, 2023 | 92.6 | -0.1 | -0.11% | 92.7 | 93.4 | 91.5 |
Jan 24, 2023 | 93.5 | -0.9 | -0.95% | 94.4 | 95.0 | 93.4 |
Jan 23, 2023 | 94.5 | -0.4 | -0.42% | 94.9 | 95.1 | 94.0 |
Jan 20, 2023 | 93.3 | 0.7 | 0.76% | 92.6 | 94.1 | 92.2 |
Jan 19, 2023 | 92.0 | -3.0 | -3.16% | 95.0 | 95.4 | 92.0 |
Jan 18, 2023 | 95.1 | 0.9 | 0.96% | 94.2 | 95.7 | 93.0 |
Jan 17, 2023 | 94.3 | -1.2 | -1.26% | 95.5 | 96.1 | 91.6 |
Jan 16, 2023 | 94.5 | 1.8 | 1.94% | 92.7 | 95.8 | 92.3 |
Jan 13, 2023 | 92.5 | 2.8 | 3.12% | 89.7 | 92.8 | 88.2 |
Jan 12, 2023 | 89.0 | 2.4 | 2.77% | 86.6 | 90.1 | 86.0 |
Jan 11, 2023 | 87.0 | 0.0 | 0.00% | 87.0 | 88.4 | 86.0 |
Jan 10, 2023 | 86.9 | 1.2 | 1.40% | 85.7 | 87.1 | 84.5 |
Jan 9, 2023 | 85.4 | -0.6 | -0.70% | 86.0 | 87.1 | 84.5 |
Jan 5, 2023 | 84.6 | -0.3 | -0.35% | 84.9 | 85.9 | 82.5 |
Jan 4, 2023 | 85.0 | -1.0 | -1.16% | 86.0 | 88.7 | 84.2 |
Biogaia B Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Jaarlijks
- Per kwartaal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Totale inkomsten | 534.696 | 615.003 | 741.87 | 768.347 | 747.077 | 785.11 |
Inkomsten | 534.696 | 615.003 | 741.87 | 768.347 | 747.077 | 785.11 |
Kosten van opbrengsten, totaal | 146.889 | 151.655 | 185.956 | 204.349 | 200.159 | 202.161 |
Brutowinst | 387.807 | 463.348 | 555.914 | 563.998 | 546.918 | 582.949 |
Totale bedrijfskosten | 335.259 | 381.17 | 464.511 | 525.836 | 518.927 | 531.373 |
Verkoop/Algemeen/Admin. Uitgaven, Totaal | 127.33 | 147.786 | 179.783 | 207.058 | 196.289 | 233.221 |
Onderzoek & Ontwikkeling | 63.532 | 75.324 | 98.776 | 103.164 | 102.84 | 102.865 |
Depreciation / Amortization | 1.934 | 1.768 | 1.945 | 3.765 | 3.296 | 4.364 |
Rentekosten (inkomsten) - Operationeel nettobedrijfsresultaat | -4.426 | 0.82 | -6.504 | 0 | 11.506 | |
Bedrijfsresultaat | 199.437 | 233.833 | 277.359 | 242.511 | 228.15 | 253.737 |
Renteopbrengsten (-uitgaven), netto Niet-operationeel | -3.256 | -0.73 | 0.641 | -0.252 | -0.567 | -1.025 |
Overige, Netto | -0.122 | -0.192 | -0.405 | |||
Netto inkomen voor belastingen | 196.059 | 232.911 | 277.595 | 242.259 | 227.583 | 252.712 |
Netto inkomen na belastingen | 159.349 | 180.564 | 214.233 | 187.258 | 179.73 | 196.273 |
Minderheidsbelang | 0.284 | 0 | 0.657 | 0.089 | 0 | 0 |
Netto inkomen voor extra. Posten | 159.633 | 180.564 | 214.89 | 187.347 | 179.73 | 196.273 |
Totale buitengewone posten | 67.935 | 0 | ||||
Netto inkomen | 227.568 | 180.564 | 214.89 | 187.347 | 179.73 | 196.273 |
Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 159.633 | 180.564 | 214.89 | 187.347 | 179.73 | 196.273 |
Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 227.568 | 180.564 | 214.89 | 187.347 | 179.73 | 196.273 |
Verwaterd Netto Inkomen | 227.568 | 180.564 | 214.89 | 187.347 | 179.73 | 196.273 |
Verwaterd Gewogen Gemiddelde Aandelen | 86.68 | 86.68 | 86.68 | 86.68 | 89.2403 | 100.963 |
Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 1.84164 | 2.08311 | 2.47912 | 2.16136 | 2.014 | 1.944 |
Dividends per Share - Common Stock Primary Issue | 1.5 | 1.8 | 2 | 1.6 | 1.364 | 1.452 |
Verwaterde Genormaliseerde Winst per Aandeel | 1.84164 | 2.08311 | 2.47912 | 2.16136 | 2.014 | 2.04477 |
Other Operating Expenses, Total | 3.817 | 4.555 | 7.5 | 16.343 | -22.744 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Totale inkomsten | 201.975 | 203.131 | 173.841 | 206.163 | 283.855 |
Inkomsten | 201.975 | 203.131 | 173.841 | 206.163 | 283.855 |
Kosten van opbrengsten, totaal | 56.775 | 52.282 | 45.975 | 47.129 | 81.647 |
Brutowinst | 145.2 | 150.849 | 127.866 | 159.034 | 202.208 |
Totale bedrijfskosten | 137.73 | 133.908 | 106.662 | 153.073 | 188.56 |
Verkoop/Algemeen/Admin. Uitgaven, Totaal | 58.943 | 51.71 | 45.567 | 78.763 | 83.098 |
Onderzoek & Ontwikkeling | 27.179 | 28.091 | 19.718 | 30.479 | 24.904 |
Other Operating Expenses, Total | -5.167 | 1.825 | -4.598 | -3.298 | -1.089 |
Bedrijfsresultaat | 64.245 | 69.223 | 67.179 | 53.09 | 95.295 |
Renteopbrengsten (-uitgaven), netto Niet-operationeel | -0.197 | -0.134 | -0.238 | -0.456 | 2.072 |
Netto inkomen voor belastingen | 64.048 | 69.089 | 66.941 | 52.634 | 97.367 |
Netto inkomen na belastingen | 50.443 | 54.711 | 52.844 | 38.275 | 76.297 |
Minderheidsbelang | 0 | 0 | 0 | 0 | |
Netto inkomen voor extra. Posten | 50.443 | 54.711 | 52.844 | 38.275 | 76.297 |
Netto inkomen | 50.443 | 54.711 | 52.844 | 38.275 | 76.297 |
Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 50.443 | 54.711 | 52.844 | 38.275 | 76.297 |
Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 50.443 | 54.711 | 52.844 | 38.275 | 76.297 |
Verwaterd Netto Inkomen | 50.443 | 54.711 | 52.844 | 38.275 | 76.297 |
Verwaterd Gewogen Gemiddelde Aandelen | 100.98 | 100.98 | 100.98 | 100.914 | 100.98 |
Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 0.49953 | 0.5418 | 0.52331 | 0.37928 | 0.75557 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 1.452 | 0 |
Verwaterde Genormaliseerde Winst per Aandeel | 0.55803 | 0.5418 | 0.52331 | 0.41964 | 0.78583 |
- Jaarlijks
- Per kwartaal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Totaal vlottende activa | 385.34 | 454.337 | 494.415 | 452.438 | 1689.58 | 1752.08 |
Geldmiddelen en kortetermijnbeleggingen | 243.082 | 310.856 | 289.794 | 218.814 | 1467.88 | 1484.68 |
Geldmiddelen & Equivalenten | 243.069 | 305.856 | 284.962 | 213.831 | 1467.88 | 1484.68 |
Korte Termijn Investeringen | 0.013 | 5 | 4.832 | 4.983 | 0 | |
Totale Vorderingen, Netto | 98.558 | 105.251 | 154.819 | 156.316 | 143.196 | 148.53 |
Accounts Receivable - Trade, Net | 92.206 | 96.832 | 142.009 | 129.763 | 101.658 | 128.152 |
Total Inventory | 40.479 | 32.612 | 44.213 | 68.445 | 72.277 | 102.737 |
Prepaid Expenses | 1.314 | 1.035 | 1.477 | 1.731 | 1.735 | 0 |
Other Current Assets, Total | 1.907 | 4.583 | 4.112 | 7.132 | 4.486 | 16.13 |
Total Assets | 488.978 | 576.112 | 659.973 | 665.9 | 1913.28 | 2128.05 |
Property/Plant/Equipment, Total - Net | 82.43 | 102.465 | 105.935 | 149.042 | 162.765 | 153.635 |
Property/Plant/Equipment, Total - Gross | 128.463 | 155.117 | 166.773 | 218.949 | 256.218 | 275.996 |
Accumulated Depreciation, Total | -46.034 | -52.654 | -60.84 | -69.909 | -93.453 | -122.361 |
Intangibles, Net | 0 | 45.85 | 52.558 | 50.322 | 48.086 | |
Long Term Investments | 10.775 | 9.971 | 0.043 | 0.044 | 0.039 | 22.272 |
Other Long Term Assets, Total | 10.433 | 9.339 | 8.43 | 6.518 | 5.279 | 2.757 |
Total Current Liabilities | 73.466 | 111.446 | 145.173 | 124.8 | 135.062 | 126.954 |
Accounts Payable | 16.951 | 20.893 | 34.009 | 28.491 | 48.046 | 42.313 |
Accrued Expenses | 25.381 | 40.887 | 57.349 | 53.913 | 48.723 | 56.399 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 31.134 | 49.666 | 53.815 | 34.83 | 30.093 | 19.342 |
Total Liabilities | 73.78 | 112.208 | 154.991 | 158.028 | 167.039 | 250.689 |
Total Long Term Debt | 0 | 0 | 0 | 17.254 | 20.7 | 10.4 |
Deferred Income Tax | 0.332 | 0.778 | 6.679 | 10.339 | 11.312 | 14.24 |
Minority Interest | -0.018 | -0.016 | 3.139 | 0.002 | 0.002 | 0.002 |
Total Equity | 415.198 | 463.904 | 504.982 | 507.872 | 1746.24 | 1877.36 |
Common Stock | 17.336 | 17.336 | 17.336 | 17.336 | 20.196 | 20.196 |
Additional Paid-In Capital | 20.096 | 43.662 | 43.662 | 21.831 | 1149.48 | 1154.01 |
Retained Earnings (Accumulated Deficit) | 377.766 | 402.906 | 443.984 | 468.705 | 576.564 | 703.161 |
Total Liabilities & Shareholders’ Equity | 488.978 | 576.112 | 659.973 | 665.9 | 1913.28 | 2128.05 |
Total Common Shares Outstanding | 83.7196 | 83.7196 | 83.7196 | 83.7196 | 98.0196 | 98.0196 |
Goodwill, Net | 5.3 | 5.3 | 5.3 | 149.227 | ||
Current Port. of LT Debt/Capital Leases | 7.566 | 8.2 | 8.9 | |||
Capital Lease Obligations | 17.254 | 20.7 | 10.4 | |||
Other Liabilities, Total | 5.633 | -0.037 | 99.093 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Totaal vlottende activa | 1711.47 | 1705.69 | 1742.81 | 1752.08 | 1849.21 |
Geldmiddelen en kortetermijnbeleggingen | 1486.77 | 1468.94 | 1529.74 | 1484.68 | 1571.69 |
Geldmiddelen & Equivalenten | 1486.77 | 1468.94 | 1529.74 | 1484.68 | 1571.69 |
Other Current Assets, Total | 224.704 | 236.753 | 213.072 | 9.768 | 277.522 |
Total Assets | 1946.15 | 1935.85 | 1967.69 | 2128.05 | 2230.16 |
Property/Plant/Equipment, Total - Net | 151.581 | 148.076 | 143.72 | 153.635 | 153.261 |
Goodwill, Net | 5.3 | 5.3 | 5.3 | 149.227 | 152.73 |
Intangibles, Net | 49.763 | 49.204 | 48.645 | 48.086 | 47.713 |
Long Term Investments | 22.271 | 22.27 | 22.271 | 22.272 | 22.273 |
Other Long Term Assets, Total | 5.759 | 5.309 | 4.944 | 2.757 | 4.97 |
Total Current Liabilities | 120.658 | 123.594 | 104.057 | 126.954 | 153.018 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 120.658 | 123.594 | 104.057 | 19.342 | 153.018 |
Total Liabilities | 148.51 | 150.846 | 128.878 | 250.689 | 273.518 |
Total Long Term Debt | 0 | 0 | 0 | 10.4 | 0 |
Deferred Income Tax | 11.218 | 11.218 | 11.218 | 14.24 | 14.19 |
Minority Interest | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 |
Other Liabilities, Total | 16.632 | 16.032 | 13.601 | 99.093 | 106.308 |
Total Equity | 1797.64 | 1785 | 1838.81 | 1877.36 | 1956.64 |
Other Equity, Total | 1797.64 | 1785 | 1838.81 | 1877.36 | 1956.64 |
Total Liabilities & Shareholders’ Equity | 1946.15 | 1935.85 | 1967.69 | 2128.05 | 2230.16 |
Total Common Shares Outstanding | 98.0196 | 98.0196 | 98.0196 | 98.0196 | 98.0196 |
Totale Vorderingen, Netto | 154.892 | ||||
Accounts Receivable - Trade, Net | 118.588 | ||||
Total Inventory | 102.737 | ||||
Accounts Payable | 42.313 | ||||
Accrued Expenses | 56.399 | ||||
Current Port. of LT Debt/Capital Leases | 8.9 | ||||
Capital Lease Obligations | 10.4 |
- Jaarlijks
- Per kwartaal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Netto-inkomen/Beginsaldo | 194.275 | 232.991 | 277.359 | 242.511 | 228.15 | 253.737 |
Geldmiddelen uit Operationele Activiteiten | 147.929 | 222.615 | 183.12 | 147.855 | 221.256 | 221.875 |
Geldmiddelen uit Operationele Activiteiten | 7.074 | 6.573 | 7.546 | 15.593 | 20.53 | 27.241 |
Niet-Geldelijke Posten | -3.966 | 2.558 | 0.591 | 3.075 | -3.709 | 0.047 |
Cash Taxes Paid | 43.381 | 49.547 | 52.408 | 72.292 | 72.092 | 55.934 |
Contant Betaalde Rente | 0.124 | 0.401 | 0.694 | |||
Veranderingen in het Operationeel Kapitaal | -49.454 | -19.507 | -102.376 | -113.324 | -23.715 | -59.15 |
Geldmiddelen uit Investeringsactiviteiten | -9.611 | -26.643 | -47.301 | -39.024 | -16.075 | -126.967 |
Kapitaaluitgaven | -5.611 | -26.624 | -13.454 | -39.024 | -16.075 | -28.608 |
Overige Cash Flow investeringsposten, Totaal | -4 | -0.019 | -33.847 | 0 | -98.359 | |
Geldmiddelen uit Financieringsactiviteiten | -124.311 | -132.421 | -158.728 | -181.09 | 1051.4 | -81.846 |
Total Cash Dividends Paid | -124.311 | -130.023 | -156.028 | -173.365 | -65.012 | -68.87 |
Uitgifte (Aflossing) van aandelen, netto | 0 | 1126.84 | 4.525 | |||
Wisselkoerseffecten | 2.18 | -0.764 | 2.015 | 1.128 | -2.525 | 3.735 |
Nettowijziging in Geldmiddelen | 16.187 | 62.787 | -20.894 | -71.131 | 1254.05 | 16.797 |
Financiering van Cash Flow Posten | -2.398 | -2.7 | -3.2 | -2.8 | -2.8 | |
Uitgifte (Aflossing) van Schulden, Netto | -4.525 | -7.632 | -14.701 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 64.245 | 133.468 | 200.647 | 253.737 | 95.295 |
Cash From Operating Activities | 41.892 | 97.655 | 165.61 | 221.875 | 93.065 |
Cash From Operating Activities | 10.363 | 15.855 | 22.106 | 27.241 | 6.049 |
Non-Cash Items | -0.189 | 1.414 | -2.786 | 0.047 | -1.136 |
Cash Taxes Paid | 17.196 | 35.88 | 52.731 | 55.934 | 17.512 |
Changes in Working Capital | -32.527 | -53.082 | -54.357 | -59.15 | -7.143 |
Cash From Investing Activities | -23.269 | -24.041 | -36.865 | -126.967 | -5.081 |
Capital Expenditures | -23.269 | -24.041 | -36.865 | -28.608 | -5.081 |
Cash From Financing Activities | -1.4 | -72.551 | -72.07 | -81.846 | -2.211 |
Financing Cash Flow Items | 0 | -2.8 | -2.8 | -2.8 | 0 |
Total Cash Dividends Paid | 0 | -68.87 | -68.87 | -68.87 | 0 |
Issuance (Retirement) of Stock, Net | 0 | 2.138 | 4.989 | 4.525 | -0.206 |
Issuance (Retirement) of Debt, Net | -1.4 | -3.019 | -5.389 | -14.701 | -2.005 |
Foreign Exchange Effects | 1.664 | -0.011 | 5.178 | 3.735 | 1.24 |
Net Change in Cash | 18.887 | 1.052 | 61.853 | 16.797 | 87.013 |
Other Investing Cash Flow Items, Total | -98.359 | 0 |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com GroupHandelaren
Actieve klanten per maand
Maandelijks beleggingsvolume
Opgenomen per maand
Handelscalculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Biogaia Company profile
Over Biogaia B
Biogaia AB is een in Zweden gevestigd gezondheidszorgbedrijf dat zich bezighoudt met de ontwikkeling en verkoop van probiotische producten. De onderneming ontwikkelt, verhandelt en verkoopt probiotische producten met gedocumenteerde gezondheidsvoordelen. De producten zijn voornamelijk gebaseerd op verschillende stammen van de melkzuurbacterie Limosilactobacillus reuteri. De activiteiten van de onderneming zijn onderverdeeld in drie segmenten: Het Paediatrics segment druppels, darmgezondheidstabletten, orale rehydratie oplossing (ORS) en culturen die gebruikt worden als ingrediënten in producten van licentiehouders; Het Adult Health segment (darmgezondheidstabletten, orale gezondheid zuigtabletten en culturen als ingrediënt in zuivelproducten van een licentiehouder) en het Other (royalty's met betrekking tot ontwikkelingsprojecten, inkomsten uit verpakkingsoplossingen in de dochteronderneming CapAble, etc.). De Vennootschap is wereldwijd actief.
Industry: | Biopharmaceuticals |
Kungsbroplan 3
STOCKHOLM
STOCKHOLM 112 27
SE
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 485.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen